Patient Guide: Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06941792
Status: 🟢 Enrolling Now
Condition: Coronary Heart Disease
Phase: PHASE4

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • Anqing, Anhui
  • • Beijing, Beijing
  • • Chongqing, Chongqing
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Inclisiran Effectiveness in China: a Pragmatic Randomized Trial - Join Clinical Trial NCTNCT06941792

How to Join This Clinical Trial - NCTNCT06941792

Learn how to participate in this PHASE4 trial studying an investigational therapy for Coronary Heart Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Coronary Heart Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Coronary Heart Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06941792 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Anqing, Anhui 246003 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing 102218 - China

Status: RECRUITING

Clinical Research Site

Chongqing, Chongqing 400010 - China

Status: RECRUITING

Clinical Research Site

Longyan, Fujian 364099 - China

Status: RECRUITING

Clinical Research Site

Jiamusi, Heilongjiang 154002 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 451400 - China

Status: RECRUITING

Clinical Research Site

Baotou, Inner Mongolia autonomous region 014010 - China

Status: RECRUITING

Clinical Research Site

Shenyang, Liaoning 110016 - China

Status: RECRUITING

Clinical Research Site

Shenyang, Liaoning 121100 - China

Status: RECRUITING

Clinical Research Site

Jining, Shandong 272000 - China

Status: RECRUITING

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Coronary Heart Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships